Semler Scientific Inc (SMLR)
23.14
-0.53
(-2.24%)
USD |
NASDAQ |
May 17, 16:00
23.14
0.00 (0.00%)
After-Hours: 20:00
Semler Scientific Enterprise Value: 104.49M for May 16, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 16, 2024 | 104.49M |
May 15, 2024 | 104.71M |
May 14, 2024 | 103.29M |
May 13, 2024 | 100.36M |
May 10, 2024 | 99.19M |
May 09, 2024 | 99.48M |
May 08, 2024 | 85.84M |
May 07, 2024 | 136.15M |
May 06, 2024 | 132.76M |
May 03, 2024 | 128.02M |
May 02, 2024 | 120.76M |
May 01, 2024 | 118.06M |
April 30, 2024 | 113.91M |
April 29, 2024 | 121.38M |
April 26, 2024 | 117.92M |
April 25, 2024 | 116.54M |
April 24, 2024 | 121.45M |
April 23, 2024 | 124.70M |
April 22, 2024 | 118.96M |
April 19, 2024 | 115.29M |
April 18, 2024 | 113.35M |
April 17, 2024 | 114.81M |
April 16, 2024 | 117.09M |
April 15, 2024 | 115.64M |
April 12, 2024 | 128.51M |
Date | Value |
---|---|
April 11, 2024 | 129.69M |
April 10, 2024 | 134.18M |
April 09, 2024 | 140.00M |
April 08, 2024 | 131.90M |
April 05, 2024 | 135.78M |
April 04, 2024 | 131.00M |
April 03, 2024 | 134.74M |
April 02, 2024 | 132.25M |
April 01, 2024 | 137.57M |
March 31, 2024 | 139.37M |
March 28, 2024 | 148.18M |
March 27, 2024 | 143.54M |
March 26, 2024 | 142.62M |
March 25, 2024 | 148.95M |
March 22, 2024 | 153.80M |
March 21, 2024 | 154.37M |
March 20, 2024 | 156.26M |
March 19, 2024 | 158.02M |
March 18, 2024 | 154.93M |
March 15, 2024 | 156.26M |
March 14, 2024 | 154.51M |
March 13, 2024 | 171.38M |
March 12, 2024 | 167.87M |
March 11, 2024 | 157.53M |
March 08, 2024 | 158.09M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
85.84M
Minimum
May 08 2024
977.58M
Maximum
Oct 29 2021
339.04M
Average
274.60M
Median
Apr 11 2022
Enterprise Value Benchmarks
Perspective Therapeutics Inc | 890.47M |
Retractable Technologies Inc | -16.18M |
Xtant Medical Holdings Inc | 106.24M |
Asensus Surgical Inc | 63.22M |
Catheter Precision Inc | 3.203M |
Enterprise Value Related Metrics
Net Income (Quarterly) | 6.073M |
Revenue (Quarterly) | 15.90M |
Total Expenses (Quarterly) | 8.927M |
EPS Diluted (Quarterly) | 0.78 |
Gross Profit Margin (Quarterly) | 92.16% |
Profit Margin (Quarterly) | 38.19% |
Earnings Yield | 12.01% |
Operating Earnings Yield | 13.14% |
Normalized Earnings Yield | 12.57 |